Health ❯ Pharmaceuticals ❯ Clinical Trials

Drug Development

Regulatory Compliance MASH Treatment Investor Impact Regulatory Affairs Regulatory Issues Prostate Cancer Lung Cancer Treatments GLP-1 Agonists Syntis Bio Safety Concerns BioAge Labs, Inc. Azelaprag Investigational Drugs

aTyr Investors Face Dec. 8 Deadline in Securities Suits Over Efzofitimod Trial Failure

Rival law firms seek to lead the case, courting shareholders from differing class periods.

aTyr Investors Face Dec. 8 Deadline as Rival Lawsuits Over Failed Sarcoidosis Trial Intensify

Jasper Therapeutics Investors Face Lead Plaintiff Deadline in Securities Class Action

New aTyr Class Action Expands Investor Window After EFZO-FIT Failure

Law Firms Urge Jasper Therapeutics Investors to Seek Lead‑Plaintiff Role Before Nov. 18 Deadline